Brian Nutt is the Vice President and Controller of Covance Drug Development, a LabCorp subsidiary. Covance is the world’s most comprehensive drug development company and the only provider of full-spectrum drug development services from early stage research to regulatory approval and beyond. Brian joined Covance in 2006 and prior to his current role has held various positions, including Principal Accounting Officer, Senior Director of External Reporting, and Director of Corporate Finance. Prior to joining Covance, Brian held positions of increasing responsibility at a number of companies including MedPointe Pharmaceuticals, Carter-Wallace, Inc. and KPMG.
Brian is a certified public accountant and holds a bachelors and masters degree in business administration from Rider University.